During the past decade, Montefiore Hospital Clinical and Translational Research Center conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Montefiore Hospital Clinical and Translational Research Center" #1 sponsor was "Amicus Therapeutics" with 1 trials, followed by "MicroDose Defense Products L.L.C." with 1 trials sponsored, "Pfizer" with 1 trials sponsored, "Stephen Y. Chan" with 1 trials sponsored and "University of Pittsburgh" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Montefiore Hospital Clinical and Translational Research Center" #1 collaborator was "Bayer" with 1 trials as a collaborator, "Friedreich's Ataxia Research Alliance" with 1 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator, "U.S. Army Space and Missile Defense Command" with 1 trials as a collaborator and "University of Pittsburgh" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Montefiore Hospital Clinical and Translational Research Center" are "Friedreich Ataxia" (1 trials), "Hemophilia A" (1 trials), "Organophosphorus Poisoning" (1 trials), "Pompe Disease (Late-onset)" (1 trials) and "Pulmonary Arterial Hypertension" (1 trials). Many other conditions were trialed in "Montefiore Hospital Clinical and Translational Research Center" in a lesser frequency.

Most popular intervention types in "Montefiore Hospital Clinical and Translational Research Center" are "Drug" (3 trials), "Biological" (2 trials) and "Diagnostic Test" (2 trials). Other intervention types were less common.

The name of intervention was led by "(18F)FPGLU" (1 trials), "18F-FGLN PET Imaging" (1 trials), "AT2221" (1 trials), "ATB200" (1 trials) and "SB-525 (PF-07055480)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Montefiore Hospital Clinical and Translational Research Center" are 4 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Montefiore Hospital Clinical and Translational Research Center". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Montefiore Hospital Clinical and Translational Research Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Montefiore Hospital Clinical and Translational Research Center, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".